Tarsus Pharmaceuticals
Price & Volume
Stats
See more52W Range | $38.51-$85.25 |
Market Cap | $3B |
Shares Short | 4M |
Financials
See moreRevenue (12 Mos) | $451.3M |
Revenue Growth (YoY) | 128.4% |
Gross Profit (12 Mos) | $356.3M |
Diluted EPS | -$1.59 |
News
See moreYahoo Finance • 20 days ago
Tarsus Pharma Stock Up 20% as Insider Sells $839K in RSU-Linked Trade
Yahoo Finance • 22 days ago
Olema Stock Up 242%, but Does a $122 Million Position Suggest More Upside Potential?
Yahoo Finance • last month
Oppenheimer Raises Its Price Target on Tarsus Pharmaceuticals, Inc. (TARS) to $105 and Maintains an Outperform Rating
Yahoo Finance • last month
These Growth Stocks Form Classic Cup Bases. Here's Where To Buy.
About
CEO | Dr. Bobak R. Azamian M.D. |
CFO | Mr. Jeffrey S. Farrow CPA |
Address | 15440 Laguna Canyon Road, Irvine, CA, United States, 92618 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 370 |
